Family Dollar recall of OTC drugs, medical devices spans 23 states
Family Dollar has a recall underway in 23 states that applies to various OTC drugs and medical devices. The affected products were "stored outside labeled temperature requirements."
Altana using AI to map and analyze global supply chain with launch of next-gen Atlas
Altana launched the newest version of its Atlas, an AI-powered map of the global supply chain used by companies and government agencies to monitor the flow of goods and their inputs.
SEC probes Elon Musk's Twitter takeover
Billionaire Elon Musk is facing a new probe from the SEC regarding possible violations of securities laws related to his $44 billion acquisition of Twitter a year ago.
Supreme Court takes up case that could determine CFPB's fate
The Supreme Court will hear arguments in a case challenging the constitutionality of the Consumer Financial Protection Bureau's funding mechanism that could create uncertainty around the regulatory agency's future.
FDA approves Novo Nordisk's Rivfloza therapy for rare kidney condition
On Monday, Novo Nordisk announced that its therapy for treating a rare genetic kidney condition has received approval from the U.S. Food and Drug Administration.
China urges US to reconsider rules on investment in tech sector
China's trade council has formally requested the United States to reconsider regulations that restrict U.S. investments in China's technology sector.
GOP state AGs hit Biden Treasury 'net-zero financing' memo as backdoor regulation by 'green cabal'
Republican state AGs say Biden Treasury Dept. net-zero "principles" for private sector financing are “compulsion of the green cabal" that "fly in the face" of legal scrutiny.
Abbott India warns of potential laxative syrup shortages amid production halt
Abbott Laboratories' Indian unit has cautioned about potential shortages of two popular laxative syrups, Cremaffin and Duphalac, due to a production halt in India's Goa state.
Biden administration announces rule to remove medical bills from credit reports
Vice President Kamala Harris and the Consumer Financial Protection Bureau announced the Biden administration is proposing a rule to remove medical debt from credit reports.
SEC issues rule cracking down on 'greenwashing' by investment funds
The Securities and Exchange Commission adopted a new rule to crack down on "greenwashing" by investment funds that deceptively market funds that aren't as ESG-friendly as they claim.
Japan halts poultry imports from Brazilian state following avian influenza outbreak
Following an outbreak of highly pathogenic avian influenza in Mato Grosso do Sul, Japan has halted its chicken imports from the Brazilian state.
Novo Nordisk shares fall after media report on quality lapses at US plant
Novo Nordisk, a pharmaceutical company, experienced a decline in its stock prices following a report by financial news agency MarketWire.
Johnson & Johnson ditching script logo after 130 years
Johnson & Johnson announced that it's ditching the classic cursive script it has used for 130 years in favor of a revamped logo that pays homage to the old design.
FDA advisory panel says widely used decongestant considered ineffective
An advisory panel for the U.S. Food and Drug Administration decided Tuesday an ingredient widely used in nasal decongestants doesn't work any better than a placebo pill.
China risks should get disclosed by large US companies, says former SEC chair
Former SEC chair Jay Clayton told the House Select Committee on the Chinese Communist Party that U.S. businesses should start disclosing their exposure to China for investors' benefit.
Federal judge rules against CFPB's anti-discrimination effort
A federal judge ruled that the Consumer Financial Protection Bureau overstepped its authority by looking to pursue regulatory actions related to anti-discrimination efforts.
Chip war heats up: China to launch $40B state fund for semiconductor manufacturing
China is planning a new $40 billion government-backed investment fund aimed at bolstering the country's semiconductor manufacturing industry that has been hit by U.S. export controls.
Narcan nasal spray is available for over-the-counter purchase in US: ‘Lifesaving drug’
Narcan (naloxone) is now available for purchase over the counter (OTC), without a prescription, in all U.S. states, Washington, D.C. and Puerto Rico. Here are details.
Federal appeals court revives lawsuit saying FDA overstepped on anti-ivermectin messaging
A federal appeals court has ruled that a lawsuit against the Food and Drug Administration for advocating against Ivermectin use can proceed.
Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drug
Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.